Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
Abdullatif Taha Babakr, Mohammed Hasan Mukhtar, Abeer Shaker Elmoursy Ali, Mohammad A Althubiti, Gad Allah Modawe, Sameer Hasan Fatani, Wesam A Nasif · 2026
Read Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes by Abdullatif Taha Babakr, Mohammed Hasan Mukhtar, Abeer Shaker Elmoursy Ali, Mohammad A Althubiti, Gad Allah Modawe, Sameer Hasan Fatani, Wesam A Nasif (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13186220.txt.
Description
Babakr and co-authors review whether chromium affects how insulin receptors work in metabolic syndrome and type 2 diabetes. Their 2026 systematic review sets out metabolic syndrome as a cluster of insulin resistance, abnormal lipids, central fat, and high blood pressure.
Chromium is a trace element that the body needs in small amounts. Low chromium has been linked with insulin resistance and diabetes, and a cycle is described in which poor glucose control leads to further chromium loss. Supplements have been tied to better insulin sensitivity in some work. The review weighs how chromium may aid insulin signaling and lipid control, and where the proof stays weak.
Catalog record
| CREATOR | Abdullatif Taha Babakr, Mohammed Hasan Mukhtar, Abeer Shaker Elmoursy Ali, Mohammad A Althubiti, Gad Allah Modawe, Sameer Hasan Fatani, Wesam A Nasif |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |